Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07218848 · ClinicalTrials.gov registry record · NA

ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area

A NA study of Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
2
Study locations

NCT07218848: Recruiting NA study of Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT07218848 is a NA study of Cancer that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 50 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07218848, a NA study of Cancer, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the study is to find out if Latino families living in rural parts of Florida are interested in learning about cancer prevention through our ProSalud program and whether it helps them make healthier choices to lower their risk of cancer. The study will also gather people's opinions about the program to find ways to improve it in the future. For the first part of our study, Latino parents with children between the ages of 6 and 12 will be invited to take part in a one-hour (or one-and-a-half-hour) workshop. The workshop will teach about healthy habits like eating well, being active, and protecting skin from the sun. For the second part of the study, some parents who participated in the workshops will be randomly chosen to join a focus group. In the focus group, they'll be asked questions to help us make the workshop better and make sure it fits the culture, needs, and preferences of Latino families in rural communities.

Primary Outcome

Acceptability will be confirmed if ≥80% of enrolled participants indicate an intention to implement behavioral recommendations.

Conditions Studied

Interventions

  • OTHER Aim 1 Workshops
  • OTHER Aim 2 Focus Groups

Study Locations (2)

Florida

  • Moffitt Cancer Center - Tampa
  • University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-05-22
Est. Completion 2026-10
Phase NA

What NCT07218848 shows while recruiting

NCT07218848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Aim 1 Workshops is the first listed.

NCT07218848 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07218848 about?

NCT07218848 is a clinical study titled "ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area". The purpose of the study is to find out if Latino families living in rural parts of Florida are interested in learning about cancer prevention through our ProSalud program and whether it helps them make healthier choices to lower their risk of cancer. The study will also gather people's opinions abo...

What is the current status of trial NCT07218848?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-05-22. Estimated completion is 2026-10.

What conditions does trial NCT07218848 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT07218848?

The interventions under investigation include: Aim 1 Workshops (OTHER), Aim 2 Focus Groups (OTHER).

Who is sponsoring clinical trial NCT07218848?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07218848 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07218848's enrollment target sits among peer trials

50 422nd of 615 higher than 179 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07218848, the US trial registry maintained by the National Library of Medicine. NCT07218848 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.